Latest innovations in biomedical research presented in Tampere

Submitted on Tue, 06/13/2017 - 12:35
Jari Hyttinen avasi konferenssin Tampere-talolla.
The Chair of the conference, Professor Jari Hyttinen from TUT welcomed over 600 participants from nearly 50 different countries.


On 11−15 June 2017, Europe’s largest biomedical engineering conference will be organised in Tampere. The conference consists of two simultaneous events: the European Medical and Biological Engineering Conference (EMBEC’17) and the Nordic-Baltic Conference on Biomedical Engineering and Medical Physics (NBC’17).

The conference is organised by BioMediTech, the joint institute of the University of Tampere and Tampere University of Technology, together with various associations in the field. BioMediTech is the largest competence centre in Finland in the field.

The conference, which is organised in the Tampere Hall, will present the latest innovations in biomedical research, such as photodynamic therapies, human spare parts, mending the nervous system by 3D printing, and magnetic imaging of the brain. Over six hundred participants from nearly fifty countries will come to the largest scientific conference in the field in Europe. Both international and Finnish top researchers will give presentations, and one of the keynote speakers is Stefan W. Hell, winner of the Nobel Prize in Chemistry in 2014.

Hell received the Nobel Prize together with Eric Betzig and William Moerner for the development of super-resolved fluorescence microscopy. The technique developed by Hell enables surpassing the resolution limitations of the light microscope by using fluorescent molecules. By doing this, it is possible to observe smaller details within cells, such as supporting structures, which has earlier been impossible with conventional light microscopy.

Hell presented his research in a keynote speech at the conference and said how the most important research work in his career began at the University of Turku in Finland in the mid-1990s.

The University of Tampere Imaging Facility (TIF) has recently had the opportunity to purchase a very high resolution microscope. The microscope will bring new possibilities to research the functions of cells and tissues, for example cancer cells, and thus develop new treatments for cancer.


Text and photo: Ida Vahtera